Glucose Indices, Health Behaviors, and Incidence of Diabetes in Australia The Australian Diabetes, Obesity and Lifestyle Study

Grants

Funding Acknowledgements

E.L.M.B. is supported by a National Health and Medical Research Council (NHMRC) (no. 379305)/National Heart Foundation Australia (no. PP 05M 2346) joint postgraduate scholarship. D.W.D. is supported by a Victorian Health Promotion Foundation Public Health Research Fellowship. A.J.C. is supported by a National Heart Foundation Australia Postgraduate scholarship (no. PP 04M 1794). The AusDiab study, coordinated by the International Diabetes Institute, gratefully acknowledges the generous support given by the NHMRC (grant no. 233200); the Australian Government Department of Health and Ageing; Abbott Australasia; Alphapharm; AstraZeneca; Aventis Pharma Bristol-Myers Squibb; City Health Centre, Diabetes Service, Canberra; Department of Health and Community Services, Northern Territory; Department of Health and Human services, Tasmania the Department of Health, New South Wales; the Department of Health, Western Australia; the Department of Health, South Australia; the Department of Human Services, Victoria; Diabetes Australia Diabetes Australia Northern Territory; Eli Lilly Australia; Estate of the Late Edward Wilson; GlaxoSmithKline the Jack Brockhoff Foundation; Janssen-Cilag; Kidney Health Australia; Marian & FH Flack Trust; Menzies Research Institute; Merck Sharp & Dohme; Novartis Pharmaceuticals Novo Nordisk Pharmaceuticals Pfizer; Pratt Foundation; Queensland Health Roche Diagnostics Australia Royal Prince Alfred Hospital, Sydney; and Sanofi Synthelabo.